Partnering - Program based model

Program based drug development contracts are the greatest cost savings model CrownBio offers. In this model, your company essentially harnesses our entire capacity for pre-clinical drug development of your targets. Pharmaceutical partnerships with Crown Bioscience allows you to:

• Accelerate drug development with program management and process improvement models that maximize value from lead-to-IND
• Optimize portfolio success to more effectively manage risk
• Access specific area expertise and proprietary resources as needed for each project
• Transform fixed costs into variable, as-needed resources
• Final deliverables IND ready

A perfect example of where your organization can capitalize would be: if you have a backlog of targets which require some critical predictive pilot data in order to make critical resource allocation decisions. Simply access our experts from production and characterization teams to produce high quality, large quantities of your target, then save time by running combination efficacy studies in clinically relevant HuPrime™ models within a well-thought out program strategy enabling success clinical trials. Our scientists with years of experience bringing drugs to market, become an extension of your own research groups and provide collective drug development knowledge as well. Collaborative decision making and comprehensive “one stop” capabilities guarantees you times savings, as well as takes advantage of our lower cost infrastructure and overhead.

Crown Biosciences’ is committed to being the experts in preclinical drug development and the engine your company can trust to take your targets to therapeutics the fastest and smartest way!